PainReform Ltd. (PRFX)

USD 2.17

(-17.18%)

Total Debt Summary of PainReform Ltd.

  • PainReform Ltd.'s latest annual total debt in 2023 was 86 Thousand USD , down 0.0% from previous year.
  • PainReform Ltd.'s latest quarterly total debt in 2024 Q2 was 59 Thousand USD , down -18.06% from previous quarter.
  • PainReform Ltd. reported annual total debt of - USD in 2022, down 0.0% from previous year.
  • PainReform Ltd. reported annual total debt of - USD in 2021, down 0.0% from previous year.
  • PainReform Ltd. reported quarterly total debt of 72 Thousand USD for 2024 Q1, down -16.28% from previous quarter.
  • PainReform Ltd. reported quarterly total debt of 86 Thousand USD for 2023 Q4, down -8.51% from previous quarter.

Annual Total Debt Chart of PainReform Ltd. (2023 - 2017)

Historical Annual Total Debt of PainReform Ltd. (2023 - 2017)

Year Total Debt Total Debt Growth
2023 86 Thousand USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD -100.0%
2019 6.17 Million USD 36.57%
2018 4.52 Million USD 21.9%
2017 3.7 Million USD 0.0%

Peer Total Debt Comparison of PainReform Ltd.

Name Total Debt Total Debt Difference
Theratechnologies Inc. 58.96 Million USD 99.854%
Harrow Health, Inc. 190.5 Million USD 99.955%
Dynavax Technologies Corporation 256.91 Million USD 99.967%
Biofrontera Inc. 5.39 Million USD 98.407%
Cronos Group Inc. 2.53 Million USD 96.614%
Sonoma Pharmaceuticals, Inc. 608 Thousand USD 85.855%
Ironwood Pharmaceuticals, Inc. 715.53 Million USD 99.988%
Kala Pharmaceuticals, Inc. 36.32 Million USD 99.763%
RedHill Biopharma Ltd. 1.17 Million USD 92.668%
Cumberland Pharmaceuticals Inc. 18.42 Million USD 99.533%
Radius Health, Inc. 365.31 Million USD 99.976%
Universe Pharmaceuticals INC 5.48 Million USD 98.431%
DURECT Corporation 20.74 Million USD 99.585%
ProPhase Labs, Inc. 21.38 Million USD 99.598%
Safety Shot Inc 1.54 Million USD 94.448%
Phibro Animal Health Corporation 525.45 Million USD 99.984%
China SXT Pharmaceuticals, Inc. 2.64 Million USD 96.752%
Alvotech 1.07 Billion USD 99.992%
Assertio Holdings, Inc. 40.91 Million USD 99.79%
Supernus Pharmaceuticals, Inc. 41.52 Million USD 99.793%
Rockwell Medical, Inc. 13.43 Million USD 99.36%
Sunshine Biopharma, Inc. 657.7 Thousand USD 86.924%
Procaps Group S.A. 285.93 Million USD 99.97%
Intra-Cellular Therapies, Inc. 16.93 Million USD 99.492%
SCYNEXIS, Inc. 15.08 Million USD 99.43%
Aytu BioPharma, Inc. 15.12 Million USD 99.432%
Viatris Inc. 18.12 Billion USD 100.0%
OptiNose, Inc. 131.74 Million USD 99.935%
SIGA Technologies, Inc. 1.46 Million USD 94.126%
Tilray Brands, Inc. 387.31 Million USD 99.978%
PetIQ, Inc. 468.3 Million USD 99.982%
Sunshine Biopharma, Inc. 657.7 Thousand USD 86.924%
Neurocrine Biosciences, Inc. 428.4 Million USD 99.98%
Guardion Health Sciences, Inc. - USD -Infinity%
Alimera Sciences, Inc. 67.39 Million USD 99.872%
Collegium Pharmaceutical, Inc. 674.28 Million USD 99.987%
Silver Spike Investment Corp. - USD -Infinity%
Shuttle Pharmaceuticals Holdings, Inc. 1.08 Million USD 92.093%
Organogenesis Holdings Inc. 119.35 Million USD 99.928%
Journey Medical Corporation 17.73 Million USD 99.515%
Petros Pharmaceuticals, Inc. 8.27 Million USD 98.961%
Alpha Teknova, Inc. 30.45 Million USD 99.718%
Clever Leaves Holdings Inc. 2.08 Million USD 95.879%
Lifecore Biomedical, Inc. 130.36 Million USD 99.934%
Cosmos Health Inc. 12.42 Million USD 99.308%
Avadel Pharmaceuticals plc 35.38 Million USD 99.757%
TherapeuticsMD, Inc. 8 Million USD 98.926%
Embecta Corp. 1.63 Billion USD 99.995%
Regencell Bioscience Holdings Limited 59.8 Thousand USD -43.796%
Talphera, Inc. - USD -Infinity%
Pacira BioSciences, Inc. 586.04 Million USD 99.985%
Incannex Healthcare Limited 373 Thousand USD 76.944%
Cyclo Therapeutics, Inc. 1.03 Million USD 91.676%
Shineco, Inc. 29.65 Million USD 99.71%
Procaps Group, S.A. 285.93 Million USD 99.97%
ANI Pharmaceuticals, Inc. 315.32 Million USD 99.973%
Aquestive Therapeutics, Inc. 98.82 Million USD 99.913%
Lantheus Holdings, Inc. 616.94 Million USD 99.986%
Alvotech 1.07 Billion USD 99.992%
Hempacco Co., Inc. 13.72 Million USD 99.373%
Eagle Pharmaceuticals, Inc. 62.46 Million USD 99.862%
Bright Green Corporation 1.85 Million USD 95.356%
Esperion Therapeutics, Inc. 540.94 Million USD 99.984%
Kamada Ltd. 8.74 Million USD 99.017%
Indivior PLC 281.6 Million USD 99.969%
Evoke Pharma, Inc. 5 Million USD 98.28%
Flora Growth Corp. 3.67 Million USD 97.658%
Cyclo Therapeutics, Inc. 1.03 Million USD 91.676%
Evolus, Inc. 126.54 Million USD 99.932%
HUTCHMED (China) Limited 86.13 Million USD 99.9%
Amphastar Pharmaceuticals, Inc. 623.64 Million USD 99.986%
Akanda Corp. 3.99 Million USD 97.849%